Cargando…

Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation

SIMPLE SUMMARY: Recently, antiplatelet agents have been shown to have anticancer effects, especially for hepatocellular carcinoma (HCC) but have never been studied in liver transplantation (LT) recipients. We investigated 468 LT patients to ensure that antiplatelet drugs (aspirin or clopidogrel) cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Mun Chae, Min, Eun-Ki, Lee, Jae Geun, Joo, Dong Jin, Kim, Myoung Soo, Kim, Deok-Gie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654602/ https://www.ncbi.nlm.nih.gov/pubmed/36358749 http://dx.doi.org/10.3390/cancers14215329

Ejemplares similares

Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma
por: Kim, Deok-Gie, et al.
Publicado: (2023)

Risk Factors for Cytomegalovirus Infection and Its Impact on Survival after Living Donor Liver Transplantation in South Korea: A Nested Case-Control Study
por: Yim, Seung Hyuk, et al.
Publicado: (2023)

Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation
por: Kim, Deok Gie, et al.
Publicado: (2019)

Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study
por: Yim, Seung Hyuk, et al.
Publicado: (2023)

Predicted Impact of the Model for End-Stage Liver Disease 3.0 in a Region Suffering Severe Organ Shortage
por: Kim, Deok-Gie, et al.
Publicado: (2023)

Unusual grafts for living-donor liver transplantation
por: Yim, Seung Hyuk, et al.
Publicado: (2023)

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
por: Kang, Incheon, et al.
Publicado: (2021)

The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
por: Kim, Kunhee, et al.
Publicado: (2023)

Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
por: Cho, Yongin, et al.
Publicado: (2019)

Successful Recovery After Veno-Arterio-Venous Extracorporeal Membrane Oxygenation Immediately Before Liver Transplantation in Multi-Organ Failure Including Acute Respiratory Distress Syndrome: A Case Report
por: Choi, Mun Chae, et al.
Publicado: (2023)

Clinical association between tacrolimus intra-patient variability and liver transplantation outcomes in patients with and without hepatocellular carcinoma
por: Kim, Hyun Jeong, et al.
Publicado: (2022)

Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation
por: Hwang, Hyeo Seong, et al.
Publicado: (2022)

Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
por: Jeong, Yong Ho, et al.
Publicado: (2021)

Clinical Features and Surveillance of Very Late Hepatocellular Carcinoma Recurrence After Liver Transplantation
por: Alshahrani, Abdulwahab A., et al.
Publicado: (2018)

Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study
por: Kim, Deok Gie, et al.
Publicado: (2022)

The recovery status from delayed graft function can predict long-term outcome after deceased donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2017)

Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report
por: Joo, Dong Jin, et al.
Publicado: (2021)

Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation
por: Lee, Jae Geun, et al.
Publicado: (2015)

Association between post-transplant serum uric acid levels and kidney transplantation outcomes
por: Kim, Deok Gie, et al.
Publicado: (2018)

Rituximab protects against development of atherosclerotic cardiovascular disease after kidney transplantation: a propensity-matched study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
por: Lee, Ju-Yeun, et al.
Publicado: (2014)

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
por: Bang, Kyunghye, et al.
Publicado: (2022)

Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry
por: Kim, Jong Man, et al.
Publicado: (2021)

Absence of antitumor effects of metformin in sorafenib-treated patients with hepatocellular carcinoma recurrence after hepatic resection and liver transplantation
por: Chung, Yong-Kyu, et al.
Publicado: (2018)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
por: Kim, Minjae, et al.
Publicado: (2021)

Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
por: Kim, Minjeong, et al.
Publicado: (2021)

Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
por: Song, Seung Hwan, et al.
Publicado: (2015)

Efficacy of rabbit anti-thymocyte globulin for steroid-resistant acute rejection after liver transplantation
por: Lee, Jae Geun, et al.
Publicado: (2016)

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Association between post-transplant uric acid level and renal allograft fibrosis: Analysis using Banff pathologic scores from renal biopsies
por: Kim, Deok Gie, et al.
Publicado: (2018)

Right anterior section graft for living-donor liver transplantation: A case report
por: Navarro, Jonathan Geograpo, et al.
Publicado: (2019)

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018)

Survival Benefit of Kidney Transplantation in Patients With End-Stage Kidney Disease and Prior Acute Myocardial Infarction
por: Kim, Deok-Gie, et al.
Publicado: (2023)

Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2019)

Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
por: Kim, Jong Man
Publicado: (2021)

Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2021)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
por: Lee, Jun Young, et al.
Publicado: (2022)

Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
por: Han, Dai Hoon, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e9f8feobhmvs662mhuo4s75tbo